In light of our present study findings, these data emphasize the potential therapeutic benefit of targeting cell-autonomous and tumor microenvironmental Sdc-1 against tumor angiogenesis of TNBC, which is worth exploring in future translational studies. The gene discussed is SDC1; the disease is neoplasm.